Q2 FY27 diagnostics revenue jumps 47% YoY, network expands to 685
CHANDAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chandan Healthcare reported Q2 FY27 diagnostics revenue of Rs 56.38 crore, up 46.66% YoY from Rs 38.44 crore. Total income rose 73.22% to Rs 71.03 crore, aided by a one-time Rs 12.03 crore gain from sale of its stake in Chandan Pharmacy. Excluding this one-time item, total income still grew 43.89% YoY. The company added 410 franchises in the quarter, taking its total network to 685, with 25 diagnostic labs and 16 radiology labs. Figures are provisional and unaudited.
Strong YoY growth in core diagnostics and rapid franchise expansion signal healthy momentum, though a Rs 12 crore one-time gain inflates headline numbers.